arrow
C

Clemens Decristoforo

nuclear medicine
H指数:55
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical study

新型二聚体双模态FAP靶向剂,具有理想的肿瘤滞留效果,适用于影像引导手术:一项临床前研究

2025-11-190
OAAI
Correction: Highlight selection of radiochemistry and radiopharmacy developments by editorial board

更正:突出由编辑委员会选定的放射化学和核药房发展内容

2025-06-020
OAAI
Highlight selection of radiochemistry and radiopharmacy developments by editorial board

由编辑委员会突出显示放射化学和放射性药物领域的发展。

2025-03-250
OA
Safety, Biodistribution, and Radiation Dosimetry of the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors

安全性、生物分布及辐射剂量学:68Ga标记的Minigastrin类似物DOTA-MGS5在晚期甲状腺髓样癌及其他神经内分泌肿瘤患者中的研究

2025-01-160
PRE
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer

[177Lu] lu-psma-i & T放射配体治疗转移性去势抵抗性前列腺癌的疗效和安全性

2024-09-030
OAAI
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
2023-07-154
OAAI